HomeMarket NewsMicro Cap StocksFDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless -...

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless – Stocks To Watch

Actionable Trade Ideas

always free


In line with FDA panel consultants who reviewed the newest analysis on the long-questioned phenylephrine, a drug ingredient utilized in a number of main decongestants utilized by thousands and thousands of People on the lookout for reduction from a stuffy nostril, is probably going no higher than a dummy capsule.

“We imagine that these new medical pharmacology and medical information are constant, substantial, and plausible, and so they affirm that orally administered [phenylephrine] just isn’t efficient at any dose that may be developed and nonetheless present an affordable margin of security,” the company’s reviewers wrote of their report.

Advisers to the FDA voted unanimously in opposition to the effectiveness of the phenylephrine present in widespread variations of Benadryl, Mucinex, Tylenol, and different medicines stocked on retailer cabinets.

For the panel’s suggestions, three oral decongestant substances, phenylpropanolamine (PPA), pseudoephedrine (PSE), and phenylephrine hydrochloride, had been included.

PPA was faraway from OTC use on account of issues of safety.

After the Fight Methamphetamine Epidemic Act of 2005, PSE turned regulated as ‘behind-the-counter,’ limiting its use within the OTC setting and leaving PE as the one remaining OTC oral decongestant.

If the FDA follows by on the panel’s suggestions, Johnson & Johnson’s JNJ current spinoff Kenvue Inc KVUE, Bayer AG BAYRYGSK Plc’s GSK spinoff Haleon Plc HLN, and Procter & Gamble Firm PGReckitt Benckiser Group RBGLY RBGPF and different drugmakers could possibly be required to tug their oral medicines containing phenylephrine from retailer cabinets. 

The producers and pharmacy retailers might additionally see some affect if the FDA deems phenylephrine ineffective.

Wall Road Journal, citing Analysis agency IRI, notes that in 2021, OTC merchandise designed to handle cough, sinus, and flu signs, together with phenylephrine-containing capsules, generated roughly $5 billion in gross sales.

Pharmacy retailers to be careful for embody CVS Well being Inc CVSWalgreens Boots Alliance Inc WBA, and Ceremony Support Corp RAD, amongst others.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.